Human coagulation factor Ⅷ (Chengdu Institute Of Biological Products)

人凝血因子Ⅷ（成都生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman coagulation factor Ⅷ (Chengdu Institute Of Biological Products)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulants
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesChengdu Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A